financetom
Business
financetom
/
Business
/
Why Are Nano Nuclear Shares Trading Higher Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Are Nano Nuclear Shares Trading Higher Today?
Aug 14, 2024 10:04 AM

Nano Nuclear Energy Inc. ( NNE ) shares are trading higher on Wednesday.

According to Benzinga Pro, Nano Nuclear Energy ( NNE ) stock gained more than 52% in the past year.

On Wednesday, Rwanda announced an agreement with the company, to advance nuclear energy development through mini-reactors in the East African nation, reported Barron’s.

According to the Rwanda Atomic Energy Board (RAEB), Nano Nuclear Energy ( NNE ) will provide technical assistance, training and education and build several small modular reactors (SMRs) and microreactors.

Also Read: XPeng Joins NIO And Li Auto In Strategic Shift – Reportedly Overhauls Structure To Boost AI Focus

Nano Nuclear Energy ( NNE ) CEO James Walker stated at a press conference in Rwanda that the construction of the SMRs and microreactors is expected to occur over the “next few years,” envisioning a “very smooth path towards a highly developed civil nuclear program.”

“In Rwanda, you have small communities with a few thousand people that doesn’t justify a big reactor system, but you could put a microreactor there and it could serve up to 3,000 people for 20 years without need for refuelling,” Walker added, according to Barron’s.

In a separate release, the company announced the appointment Daniel M. Donovan Jr., a former U.S. congressman, to its executive advisory board. Donovan has been appointed as the chairman for Market Intelligence.

Price Action: NNE shares are trading higher by 20.15% to $7.99 at last check Wednesday.

Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Read Next: 

As Nvidia Leads Magnificent 7 Volatility, Analyst Says These Mega-Caps Are Poised To Outperform Small-Caps — But There’s A Catch

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
T. Rowe Price Group's Q2 Adjusted Earnings, Net Revenue Rise
T. Rowe Price Group's Q2 Adjusted Earnings, Net Revenue Rise
Jul 26, 2024
07:36 AM EDT, 07/26/2024 (MT Newswires) -- T. Rowe Price Group ( TROW ) reported Q2 adjusted earnings Friday of $2.26 per diluted share, up from $2.02 a year earlier. Analysts polled by Capital IQ expected $2.28. Net Revenue for the quarter ended June 30 was $1.73 billion, up from $1.61 billion a year earlier. Analysts surveyed by Capital IQ...
Balchem's Q2 Earnings, Net Sales Rise
Balchem's Q2 Earnings, Net Sales Rise
Jul 26, 2024
07:32 AM EDT, 07/26/2024 (MT Newswires) -- Balchem ( BCPC ) reported Q2 adjusted earnings Friday of $1.09 per diluted share, up from $1.06 a year earlier. Two analysts surveyed by Capital IQ expected $1.04. Net sales for the quarter ended June 30 was $234.1 million, compared with $231.3 million a year earlier. Three analysts surveyed by Capital IQ expected...
Osisko Development to Resume Activities at Cariboo Project in British Columbia After Wildfires
Osisko Development to Resume Activities at Cariboo Project in British Columbia After Wildfires
Jul 26, 2024
07:36 AM EDT, 07/26/2024 (MT Newswires) -- Osisko Development ( ODV ) said on Friday that it will resume activities at the Cariboo gold project in British Columbia after authorities lifted a wildfire evacuation order. The wildfires didn't affect mine site infrastructure and all access roads to the project are open, Osisko said, adding that it will continue to monitor...
Akero Therapeutics Insider Sold Shares Worth $4,381,867, According to a Recent SEC Filing
Akero Therapeutics Insider Sold Shares Worth $4,381,867, According to a Recent SEC Filing
Jul 26, 2024
07:32 AM EDT, 07/26/2024 (MT Newswires) -- William Richard White, Chief Financial Officer, around July 23, 2024, sold 161,855 shares in Akero Therapeutics ( AKRO ) for $4,381,867. Following the Form 4 filing with the SEC, White has control over a total of 41,791 shares of the company, with 41,791 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1744659/000095017024086659/xslF345X03/ownership.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved